Dosing and uses of MSUD Maxamaid
Adult dosage forms and strengths
Not indicated
Pediatric dosage forms and strengths
Dependent upon age, body weight, and medical condition; use under medical supervision
Intake is adjusted to maintain normal growth and development
Per 100 g of powder, MSUD Maxamaid provides 25 g of protein equivalent
Suggested uses of MSUD Maxamaid
Orange flavored, isoleucine-, leucine-, and valine-free powdered medical food for the dietary management of maple syrup urine disease (MSUD) in children aged 1 to 8 years
MSUD Maxamaid adverse (side) effects
Studies not conducted
Warnings
Contraindications
None
Cautions
<1 year old
Not intended as a sole source of nutrition
Not for parenteral use.
Must be consumed in conjunction with natural protein, fluid and other nutrients in quantities prescribed by a physician or dietitian to meet isoleucine, leucine and valine and general nutrition requirements
Pregnancy and lactation
Pregnancy category: N/A, for pediatric use only
Lactation: N/A, for pediatric use only
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.
Pharmacology of MSUD Maxamaid
Kinetic info: studies not conducted
Osmolality
1 to 7 dilution: 680 mOsm/kg
1 to 5 dilution: 940 mOsm/kg
Mechanism of action
N/A
